EP0929810A2 - Homogenes verfahren zur bestimmung von energieübertragung bei lumineszenz-assays - Google Patents

Homogenes verfahren zur bestimmung von energieübertragung bei lumineszenz-assays

Info

Publication number
EP0929810A2
EP0929810A2 EP97919087A EP97919087A EP0929810A2 EP 0929810 A2 EP0929810 A2 EP 0929810A2 EP 97919087 A EP97919087 A EP 97919087A EP 97919087 A EP97919087 A EP 97919087A EP 0929810 A2 EP0929810 A2 EP 0929810A2
Authority
EP
European Patent Office
Prior art keywords
acceptor
donor
energy transfer
assay
label
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97919087A
Other languages
English (en)
French (fr)
Inventor
Ilkka Antero HEMMILÄ
Pertti Juhani Hurskainen
Kaj Runar Blomberg
Veli-Matti Mukkala
Harri Juha Takalo
Satu Anneli Kovanen
Stuart Alan Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wallac Oy
Original Assignee
Wallac Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallac Oy filed Critical Wallac Oy
Publication of EP0929810A2 publication Critical patent/EP0929810A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6408—Fluorescence; Phosphorescence with measurement of decay time, time resolved fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates

Definitions

  • temporal discrimination time-resolution
  • organic donor-acceptor pairs of different decay times using pyrene as the long excited state donor, pulsed laser for excitation and phycoerythrin as the short decay-time acceptor (US 4,822,733).
  • time-resolved energy transfer principle is applied for homogeneous solution hybridization using fluorescein (Morrison et al (1989) Illrd International Symposium on Quantitative Luminescence Spectrometry in Biomedical Sciences, Ghent Belgium) as acceptor.
  • a particularly preferred group of long excited state lifetime lanthanide chelates are Compounds 1 to 12 the structure of which is dislosed in Scheme 1 to 5.
  • ⁇ exc means excitation wavelength, ⁇ decay time and G x ⁇ luminescence yield.
  • the values given in the schemes are measured from the compound coupled to a protein. 98/15830
  • covalently conjugated probes e.g. those of xanthene dyes (rhodamine, tetramethylrhodamine, Texas
  • the great number of acceptor molecules may compensate the long distance after bead coating, and the luminescent bead actually provide a energy accepting surface.
  • the bead can absorb most of the donor emitted light, a simple radiative enery transfer can be applied, in which the energy transfer is a function of space angle and critical distance with 10 ⁇ m beads is in the range of micrometers.
  • the binding proteins e.g. agglutinin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP97919087A 1996-10-04 1997-09-19 Homogenes verfahren zur bestimmung von energieübertragung bei lumineszenz-assays Withdrawn EP0929810A2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI963989 1996-10-04
FI963989A FI963989A (fi) 1996-10-04 1996-10-04 Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
PCT/FI1997/000560 WO1998015830A2 (en) 1996-10-04 1997-09-19 Homogenous luminescence energy transfer assays

Publications (1)

Publication Number Publication Date
EP0929810A2 true EP0929810A2 (de) 1999-07-21

Family

ID=8546810

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97919087A Withdrawn EP0929810A2 (de) 1996-10-04 1997-09-19 Homogenes verfahren zur bestimmung von energieübertragung bei lumineszenz-assays

Country Status (4)

Country Link
EP (1) EP0929810A2 (de)
JP (1) JP2001502055A (de)
FI (1) FI963989A (de)
WO (1) WO1998015830A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1933151A1 (de) 2006-12-15 2008-06-18 F. Hoffmann-La Roche Ag Prüfungen zum Messen der Phosphatmodifikationsenzymaktivität

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998146A (en) * 1998-07-17 1999-12-07 Wallac Oy Homogeneous luminescence assay method based on energy transfer
EP1141404A1 (de) * 1998-12-24 2001-10-10 Aclara BioSciences, Inc. Individuell adressierbare feste oberflächen, geeignet für parallele analysen
FR2792072A1 (fr) * 1999-04-08 2000-10-13 Cis Bio Int Methode homogene de detection ou de determination d'une interaction chimique ou physicochimique
WO2001040805A1 (en) * 1999-11-30 2001-06-07 Akzo Nobel N.V. Steroid compounds for steroid receptor binding assays
CA2333346C (en) * 2000-01-31 2013-01-22 The Penn State Research Foundation Interrogation of changes in the contents of a sealed container
FI20000333A0 (fi) 2000-02-16 2000-02-16 Jussi Nurmi Homogeeninen menetelmä polynukleotidin havaitsemiseksi
US7160735B2 (en) 2000-04-28 2007-01-09 Monogram Biosciences, Inc. Tagged microparticle compositions and methods
US7771929B2 (en) 2000-04-28 2010-08-10 Monogram Biosciences, Inc. Tag library compounds, compositions, kits and methods of use
FR2809817B1 (fr) * 2000-06-02 2003-08-15 Cis Bio Int Procede de detection de presence d'un liquide dans un melange
DE10058596A1 (de) * 2000-11-25 2002-06-06 Aventis Pharma Gmbh Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung
WO2002088733A1 (fr) 2001-04-23 2002-11-07 Eiken Kagaku Kabushiki Kaisha Methode d'analyse faisant intervenir une interaction intermoleculaire par rapporteur (marqueur)
AU2002305658A1 (en) 2001-05-21 2002-12-03 Aclara Biosciences, Inc. Analyzing phosphorylated proteins
AU2002310012A1 (en) 2001-05-21 2002-12-03 Monogram Biosciences, Inc. Methods and compositions for analyzing proteins
WO2002097112A2 (en) 2001-05-26 2002-12-05 Aclara Biosciences, Inc. Catalytic amplification of multiplexed assay signals
US7211440B2 (en) * 2002-03-08 2007-05-01 Wallac Oy Dissociative fluorescence enhancement assay
US20040229294A1 (en) 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
JP4206378B2 (ja) 2002-07-08 2009-01-07 哲雄 長野 蛍光プローブ
EP1608980B1 (de) * 2003-03-28 2007-08-15 SOUKKA, Tero Bioassay mit energietransfer mit homogener lumineszenz
US7696245B2 (en) 2003-03-28 2010-04-13 Sekisui Medical Co., Ltd. Fluorescent probe for zinc
FI20030460A0 (fi) 2003-03-28 2003-03-28 Tero Soukka Homogeeninen määritysmenetelmä, joka perustuu luminesenssienergiasiirtoon
EP1673634B1 (de) * 2003-10-01 2008-08-06 Wallac Oy Verbesserter homogenener zeitaufgelöster energietransfertest
WO2005062048A1 (de) * 2003-12-01 2005-07-07 Dade Behring Marburg Gmbh Homogenes nachweisverfahren
JP2005194244A (ja) 2004-01-09 2005-07-21 Shigenobu Yano 亜鉛イオン蛍光センサー
DE112005002567T5 (de) * 2004-10-19 2007-11-22 Wallac Oy Eine neue Sonde und deren Verwendung in Bioaffinitäts-Analysen
DE112005002636T5 (de) * 2004-10-22 2007-09-06 Wallac Oy Hochempfindliche homogene Analyse auf der Grundlage einer FRET-Messung mit Anti-Stokes-Verschiebung
JP4683572B2 (ja) * 2005-01-28 2011-05-18 塩野義製薬株式会社 組換え蛋白質の定量法
WO2006125855A1 (en) * 2005-05-24 2006-11-30 Hidex Oy Correction method and measurement device for anti-stokes photoluminescence measurement
WO2007077291A1 (en) 2005-12-30 2007-07-12 Turun Yliopisto Method for determination of concentration, charge or unit size of a substance
WO2007125822A1 (ja) * 2006-04-28 2007-11-08 Tokyo Institute Of Technology 薬剤スクリーニングのための複合体
EP2053059A1 (de) 2007-10-26 2009-04-29 Sanofi-Aventis Komplexe von TRPC-Domänen und SESTD1 Domänen und Verfahren und Verwendungen damit
US8652785B2 (en) 2008-12-04 2014-02-18 Sanofi Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1
EP2226633A1 (de) 2009-03-06 2010-09-08 Charité - Universitätsmedizin Berlin Verwendungen und Verfahren zur Identifikation einer zytoprotektiven Verbindung mit gp130 oder LIFRalpha
JP5732452B2 (ja) * 2009-04-30 2015-06-10 セイエス ビオ アンテルナショナル Ｖｆｔドメイン膜タンパク質のダイマーを調節する化合物の検出方法
EP2267152A1 (de) 2009-06-26 2010-12-29 Sanofi-Aventis Testsystem zum Messen der MEST-Aktivität, sowie Verfahren und Verwendungen damit
EP2320236A1 (de) 2009-11-06 2011-05-11 Sanofi-aventis Verfahren und Verwendungen im Zusammenhang mit der Identifizierung einer am Schmerz beteiligten Verbindung sowie Verfahren zur Diagnose von Algesie
EP2348130A1 (de) 2010-01-21 2011-07-27 Sanofi Verfahren und Verwendungen im Zusammenhang mit der Identifizierung einer am Schmerz beteiligten Verbindung sowie Verfahren zur Diagnose von Algesie
EP2348128A1 (de) 2010-01-21 2011-07-27 Sanofi Verfahren und Verwendungen im Zusammenhang mit der Identifizierung einer am Schmerz beteiligten Verbindung sowie Verfahren zur Diagnose von Algesie
EP2348129A1 (de) 2010-01-21 2011-07-27 Sanofi Verfahren und Verwendungen im Zusammenhang mit der Identifizierung einer am Schmerz beteiligten Verbindung sowie Verfahren zur Diagnose von Algesie
WO2011113888A1 (en) 2010-03-18 2011-09-22 Sanofi-Aventis Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
US20130079238A1 (en) 2010-03-18 2013-03-28 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
WO2011113890A1 (en) 2010-03-18 2011-09-22 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2390348A1 (de) 2010-05-25 2011-11-30 Sanofi Verfahren und Verwendungen im Zusammenhang mit der Identifizierung einer am Schmerz beteiligten Verbindung sowie Verfahren zur Diagnose von Algesie
EP2390349A1 (de) 2010-05-25 2011-11-30 Sanofi Verfahren und Verwendungen im Zusammenhang mit der Identifizierung einer am Schmerz beteiligten Verbindung sowie Verfahren zur Diagnose von Algesie
EP2532755A1 (de) 2011-06-10 2012-12-12 Sanofi-Aventis Verfahren und Verwendungen auf Grundlage der Slfn2 Expression zur Identifizierung und Profilierung von Verbindungen zur Verwendung bei der Behandlung oder Vorbeugung von Schmerzen
CN102353790B (zh) * 2011-06-25 2014-03-05 南方医科大学 一种甲胎蛋白的均相时间分辨荧光分析方法
EP2864783A4 (de) 2012-06-22 2016-02-10 Univ Macquarie Multiplex-suspensionsassay/-array mittels lebensdauercodierung
BR112015025832B1 (pt) 2013-04-15 2022-03-15 Wallac Oy Método e dispositivo para correção de diafonia e instrumento de medida
CN104181310A (zh) * 2014-07-30 2014-12-03 美艾利尔（上海）诊断产品有限公司 一种检测β-hCG含量的时间分辨免疫荧光试剂盒及其制备方法和应用
SG11202002065VA (en) 2017-09-13 2020-04-29 Progenity Inc Preeclampsia biomarkers and related systems and methods
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
FI130554B (en) 2020-01-20 2023-11-16 Oy Arctic Partners Ab LUMINESCENCE HYBRIDIZATION DETERMINATION METHOD

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996143A (en) * 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
US4868103A (en) * 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
EP0272320B1 (de) * 1986-06-17 1994-03-23 Baxter Diagnostics Inc. Homogenes fluortestverfahren mit abstoss des fluorzenten hintergrundes.
US5194300A (en) * 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
GB8820887D0 (en) * 1988-09-06 1988-10-05 Atomic Energy Authority Uk Detecting selected species
US5326692B1 (en) * 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
FR2664699B1 (fr) * 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
FR2664702B1 (fr) * 1990-07-13 1993-08-06 Cis Bio Int Procede de reduction d'interferences dans un dosage par fluorescence.
US5457186A (en) * 1993-10-13 1995-10-10 Wallac Oy Luminescent lanthanide chelates with decreased non-radiative energy loss
US5622821A (en) * 1994-06-29 1997-04-22 The Regents Of The University Of California Luminescent lanthanide chelates and methods of use
FI96367C (fi) * 1994-10-17 1996-06-10 Erkki Juhani Soini Biospecifinen määritysmenetelmä
US5741657A (en) * 1995-03-20 1998-04-21 The Regents Of The University Of California Fluorogenic substrates for β-lactamase and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9815830A2 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1933151A1 (de) 2006-12-15 2008-06-18 F. Hoffmann-La Roche Ag Prüfungen zum Messen der Phosphatmodifikationsenzymaktivität

Also Published As

Publication number Publication date
WO1998015830A3 (en) 1998-06-18
FI963989A0 (fi) 1996-10-04
JP2001502055A (ja) 2001-02-13
WO1998015830A2 (en) 1998-04-16
FI963989A (fi) 1998-04-05

Similar Documents

Publication Publication Date Title
WO1998015830A2 (en) Homogenous luminescence energy transfer assays
EP0973036B1 (de) Auf Energieübertragung gegründetes homogenes lumineszierendes Testverfahren
Yuan et al. Lanthanide complex-based fluorescence label for time-resolved fluorescence bioassay
Hemmilá et al. Time-resolution in fluorometry technologies, labels, and applications in bioanalytical assays
EP2703816B1 (de) Biosensor zur erkennung mehrerer epitope auf einem ziel
AU688928B2 (en) Luminescent lanthanide chelates and methods of use
US5656207A (en) Detecting or quantifying multiple analytes using labelling techniques
JP5841525B2 (ja) 蛍光アッセイ法
US20080174766A1 (en) Correction Method and Measurement Device For Anti-Stokes Photoluminescence Measurement
US6908769B2 (en) Dye pair for fluorescence resonance energy transfer (FRET) measurements
JP2012521208A5 (de)
EP2118658B1 (de) Verbessertes bioassay mit homogener lumineszenz
CA2261758A1 (en) Assays employing electrochemiluminescent labels and electrochemiluminescence quenchers
Deshpande Principles and applications of luminescence spectroscopy
WO1991000511A1 (en) Detecting or quantifying multiple analytes using labelling techniques
Motson et al. Potential applications for the use of lanthanide complexes as luminescent biolabels
EP1957670B1 (de) Homogener lumineszenz-bioassay
O'Riordan et al. Monofunctional derivatives of coproporphyrins for phosphorescent labeling of proteins and binding assays
Kolb et al. Homogeneous, time-resolved fluorescence method for drug discovery
Selvin Lanthanide-labeled DNA
US20060115842A1 (en) Highly sensitive homogeneous assay based on anti-Stokes' shift FRET measurement
Kokko et al. Particulate and soluble Eu (III)-chelates as donor labels in homogeneous fluorescence resonance energy transfer based immunoassay
Wolfbeis et al. Advanced luminescent labels, probes and beads and their application to luminescence bioassay and imaging
US6951760B2 (en) Diagnostic neodymium(III), ytterbium(III), or erbium(III) ion-ligand complexes
Kokko Lanthanide Chelates as donors in fluorescence resonance energy transfer: exciting prospects for bioaffinity assay detection

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981123

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): CH DE ES FR GB IT LI NL SE

17Q First examination report despatched

Effective date: 20011214

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030402